Sort   by:  
 Page size 
UnknownRenewable Resources for Enantiodiscrimination: Chiral Solvating Agents for NMR Spectroscopy from Isomannide and Isosorbide.
Not available
S-EPMC9552179 | biostudies-literature
UnknownComparative efficacy of first-line natalizumab vs IFN-β or glatiramer acetate in relapsing MS.
Not available
S-EPMC4828679 | biostudies-literature
UnknownSacubitril/valsartan reduces indications for arrhythmic primary prevention in heart failure with reduced ejection fraction: insights from DISCOVER-ARNI, a multicenter Italian register.
Not available
S-EPMC9242049 | biostudies-literature
UnknownConfirmed disability progression as a marker of permanent disability in multiple sclerosis.
Not available
S-EPMC9539581 | biostudies-literature
UnknownVariability of the response to immunotherapy among subgroups of patients with multiple sclerosis.
Not available
S-EPMC10946605 | biostudies-literature
UnknownEarly non-disabling relapses are important predictors of disability accumulation in people with relapsing-remitting multiple sclerosis.
Not available
S-EPMC10278381 | biostudies-literature
UnknownExtended pharmacological thromboprophylaxis and clinically relevant venous thromboembolism after major abdominal and pelvic surgery: international, prospective, propensity score-weighted cohort study.
Not available
S-EPMC11894929 | biostudies-literature
Sort   by:  
 Page size